Adenoviral vector-mediated gene transfer: Timing of wild-type p53 gene expression in vivo and effect of tumor transduction on survival in a rat glioma brachytherapy model

Journal of Neuro-Oncology

Volumn 49, Issue 1, 2000, Pages 27-39

  Bampoe, J ^a   Glen, J ^a   Hubbard, S L ^b   Salhia, B ^a   Shannon, P ^c   Rutka, J ^b   Bernstein, M ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

p53 gene therapy; Radiation enhancement; Rat brain tumor model; Survival times

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DOSIMETRY; GENE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOMA; IN VIVO STUDY; MALE; NONHUMAN; RADIATION INJURY; RADIATION RESPONSE; RAT; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ANIMALS; BRACHYTHERAPY; BRAIN NEOPLASMS; CELL DIVISION; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, P53; GENETIC VECTORS; GLIOMA; MALE; RATS; RATS, INBRED F344; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033668590     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006476608036     Document Type: Article

References (61)

1. Effect of implant dose/volume and surgical resection on survival in a rat glioma brachytherapy model: Implications for brain tumor therapy
2. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma
3. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma
4. Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants
5. Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiation fields
6. Assumptions in the radiotherapy of glioblastoma
7. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms
8. Clinical patterns of failure following stereotactic irradiation for malignant gliomas
9. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost
10. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
11. A randomized trial of interstitial radiotherapy (RT) boost for newly diagnosed malignant glioma
12. Advances in radiotherapy of brain tumors: Radiobiology versus reality
13. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms
14. Dose escalation using 3D conformal radiotherapy for high grade astrocytomas
15. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma-possible advantage observed at 72.0 Gy in 1.2 Gy BID fractions: Report of the Radiation Therapy Oncology Group Protocol 8302
16. Cellular and molecular targets in normal tissue radiation injury
17. p53 status and the efficacy of cancer therapy in vivo
18. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
19. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy
20. Role of three cancer 'master genes' p53, bcl2 and c-myc on the apoptotic process
21. p53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency
22. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytoma
23. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
24. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer
25. Control of angiogenesis in fibroblasts by p53 regulation of throbospondin-1
26. Release of an inhibitor of angio-genesis upon induction of wtp53 expression in glioblastoma cells
27. Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats
28. Adenovirus-mediated p53 gene delivery potentiates the radiation-induced growth inhibition of experimental brain tumors
29. Enhancement of radiosensitivity of wtp53 human glioma cells by adenovirus-mediated delivery of the p53 gene
30. High-efficiency gene transfer and high-level expression of wtp53 in human lung cancer cells mediated by recombinant adenovirus
31. Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cells
32. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosorea
33. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(chloroethyl)-1-nitrosourea
34. Relation of apoptosis to cancer therapy
35. DNA strand breaks and chromosomal aberrations
36. Radiation necrosis of the brain: Correlation between patterns on computed tomography and dose of radiation
37. Therapeutic irradiation and brain injury
38. Effects of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy
39. Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme
40. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas
41. Thymocyte apoptosis induced by p53-dependent and independent pathways
42. p53 is required for radiation-induced apoptosis in mouse thymocytes
43. A death in the life of p53
44. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells
45. p53, guardian of the genome
46. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
47. Model tumor systems
48. Use of wtp53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53
49. The dominating effect of mutant p53
50. Negative effects of wtp53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy
51. Therapeutic implications of brain tumor cell kinetics
52. Chemotherapy of gliomas
53. In situ retroviral-mediated gene transfer for the treatment of brain tumors
54. Chemotherapeutic implications of early tumor cell growth in an animal brain-tumor model
55. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
56. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
57. Gene therapy for glioblastoma multiforme: In vivo transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
58. An adenovirus vector for gene transfer into neurons and glia in the brain
59. Anti-oncogene and tumor suppressor gene therapy - Examples from a lung cancer animal model
60. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
61. Cerebral astrocytomas and their derivatives